SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is trending as discussions swirl around potential partnerships with rivals like AMD and Apple for its foundry business, fueled by reports and government initiatives to bolster domestic chip manufacturing. Community members debate the implications of these partnerships, potential for revenue growth, and impact on Intel's valuation, with some expressing optimism about a turnaround driven by government support and AI advancements. Others caution about execution risks and the need for concrete results to justify the stock's recent gains.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is generating buzz as the community rallies to get it trending, emphasizing its active development team and engaged community. Discussions highlight the coin's utilities, ongoing contests, and upcoming staking features, positioning it as more than just another meme coin in the Solana ecosystem. Some users have also expressed excitement for 'Uptober'.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. It provides online news services where users can select and rank web content. The firm also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Shares of RDDT are seeing increased discussion as the stock experiences volatility, with a sharp decline attributed to rumors of ChatGPT reducing its reliance on Reddit data. The community is debating whether this dip represents a buying opportunity or a sign of further declines, while some are pointing to broader market trends and short-selling activity as contributing factors. Sentiment is mixed, with some expressing concerns about the platform's content and moderation policies.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DKNG is trending downwards amidst concerns that prediction markets, like Kalshi and Robinhood, are gaining traction and posing a competitive threat. The community is actively discussing the potential impact on DraftKings' market share and revenue, with some criticizing the company's leadership for not adapting quickly enough. Investors are also monitoring broader industry trends, including regulatory developments and the potential for increased competition.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly is trending due to positive sentiment around its potential in the weight loss and diabetes drug market, fueled by a new facility announcement and promising trial data for its oral GLP-1.  The community is actively discussing its competitive positioning against Novo Nordisk and speculating on potential acquisitions in the sector. Some investors are also considering the impact of potential government actions, such as tariffs and direct consumer pricing initiatives.

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending as chatter revolves around a potential collaboration with Intel as a foundry customer, sparking debate about its impact and the competitive landscape with TSMC and Samsung. Community members are actively discussing the news' validity, potential benefits, and AMD's overall valuation amidst the ever-evolving semiconductor sector. Technical analysis and price target speculation are also contributing to the heightened interest in the stock.

Rezolve AI Plc operates in the mobile commerce industry with its cutting-edge engagement platform powered by artificial intelligence and machine learning. It develops AI-based mobile commerce and engagement solutions, simplifying the purchasing process by providing relevant information and facilitating seamless transactions with a single tap. The company enables retailers, brands, and manufacturers to create dynamic connections with consumers across mobile and desktop devices. Rezolve Ai was founded in 2016 and is headquartered in London, the United Kingdom.

Rezolve AI PLC .

Rezolve AI Limited

Rezolve AI ($RZLV) is trending due to significant volatility following earnings, with community debate centered on the company's future growth and valuation. A short report from Fuzzy Panda is adding to the uncertainty, while bulls point to raised ARR guidance and potential short squeeze setups. The stock's price action and high trading volume are attracting attention as investors digest conflicting viewpoints.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending amid social media discussions spurred by Elon Musk's call to cancel subscriptions, citing concerns over content aimed at children and related controversies. The community is debating the impact of these sentiments on the stock's value, while some defend Netflix, pointing to its strong fundamentals and subscriber base. Technical analysis suggests key support and resistance levels are being closely watched as the stock navigates market sentiment.

Zcash is a decentralized and open-source cryptocurrency that offers privacy and selective transparency of transactions. Zcash payments are published on a public blockchain, but the sender, recipient, and amount of a transaction remain private.  Zcash is based on peer-reviewed cryptographic research, and built by a security-specialized engineering team on an open source platform based on Bitcoin Core's battle-tested codebase. Our improvement over Bitcoin is the addition of privacy. Zcash uses advanced cryptographic techniques, namely zero-knowledge proofs, to guarantee the validity of transactions without revealing additional information about them.  How Zcash works  Zcash encrypts the contents of shielded transactions. Since the payment information is encrypted, the protocol uses a novel cryptographic method to verify their validity.  Zcash uses a zero-knowledge proof construction called a zk-SNARK, developed by our team of experienced cryptographers based on recent breakthroughs in cryptography. These constructions allow the network to maintain a secure ledger of balances without disclosing the parties or amounts involved. Instead of publicly demonstrating spend-authority and transaction values, the transaction metadata is encrypted and zk-SNARKs are used to prove that nobody is cheating or stealing.  Zcash also enables users to send public payments which work similarly to Bitcoin. With the support for both shielded and transparent addresses, users can choose to send Zcash privately or publicly. Zcash payments sent from a shielded address to a transparent address reveal the received balance, while payments from a transparent address to a shielded address protect the receiving value.   Check out CoinBureau for guide on What is ZCash.

Zcash

Zcash is gaining attention as discussions around privacy and decentralized finance intensify, particularly with its upcoming halving event. Community members are debating its potential, use cases for shielded transactions, and some believe ZEC is undervalued relative to other cryptocurrencies like Bitcoin and Monero. Recent integrations with wallets and DEXs and broader privacy initiatives may also be contributing to the increased interest.

Enovix Corp. engages in the design and development of silicon-anode lithium-ion batteries. The firm's proprietary 3D cell architecture increases energy density and maintains a high cycle life. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable utilization of renewable energy. The company was founded by Mr. Harrold Jones Rust, III, Ashok Lahiri, and Murali Ramasubramanian in November 2006 and is headquartered in Fremont, CA.

Enovix Corporation

Enovix Corp

Enovix is trending as the community anticipates potential news, possibly a purchase order, with speculation around the company's batteries being featured in upcoming Meta products. Community members are actively discussing chart patterns, potential short squeezes, and the significance of the company's technology in the battery sector. Some traders express concerns about the valuation and long-term prospects, while others remain bullish, citing the potential for significant growth and market disruption.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ATYR We&#39;ll SEE $25+ for sure but check this shit out! WELLS FARGO SEES $50+!!!!!!! 
 
$ATYR trial enrolled 268 patients split into three groups: 89 on (3.0 mg dose) 89 on(5.0 mg dose) and 90 on a placebo.    The total number of patients on the active drug is 178. 
 
What $ATYR did…  CHANGES the probability of each scenario BIG TIME! 
 
Bull Case ($58.00+): A relapse rate below 3% is HIGHLY PROBABLE! The trial&#39;s EXCLUSION of patients with significant fibrosis, WHO HAD WORSE outcomes in Phase 2, raises the likelihood of only 5 patients or fewer relapsing out of 178 on the drug. 
 
Base Case ($25.00+)**MOST LIKELY: A relapse rate similar to Phase 2 at 7.7% is most likely to occur. The Phase 3 trial&#39;s design is meant to improve from Phase 2’s previous results.  A 7.7% rate in phase 3 = 14 patients relapsing. *(178 in groups: &lt;&lt;11 groups (19 each) = 11.5 relapses&gt;&gt;meaning they&#39;d EXCEED their 7.7% best case from phase 2. Stock price hits $25+    
even if they meet the 7.7% we good for $15!    
***

Alex

Sithma uduwela

Bullfinder

Nuh eye uh list HUGZ

potatows

Logan Roth

Racerock998

Freshh

ZUMZAP

OortBelt

Aaron Brown

Dustin Schirer

Dew' Moore

Rob Goldsmith

Roger Berger

mspridgep

Dwight Baker

Flok

Sanho

StockTwits Web

aTyr Pharma, Inc

 We'll SEE $25+ for sure but check this shit out! WELLS FARGO SEES $50+!!!!!!! 
 


 trial enrolled 268 patients split into three groups: 89 on (3.0 mg dose) 89 on(5.0 mg dose) and 90 on a placebo.    The total number of patients on the active drug is 178. 
 
What 

 did…  CHANGES the probability of each scenario BIG TIME! 
 
Bull Case ($58.00+): A relapse rate below 3% is HIGHLY PROBABLE! The trial's EXCLUSION of patients with significant fibrosis, WHO HAD WORSE outcomes in Phase 2, raises the likelihood of only 5 patients or fewer relapsing out of 178 on the drug. 
 
Base Case ($25.00+)**MOST LIKELY: A relapse rate similar to Phase 2 at 7.7% is most likely to occur. The Phase 3 trial's design is meant to improve from Phase 2’s previous results.  A 7.7% rate in phase 3 = 14 patients relapsing. *(178 in groups: <<11 groups (19 each) = 11.5 relapses>>meaning they'd EXCEED their 7.7% best case from phase 2. Stock price hits $25+    
even if they meet the 7.7% we good for $15!    
***

@dewmoore 50 percent chance is awful in biotech as most fail. The market is expecting an excellent readdout. Anything short is awful.

StockTwits For Android 

 50 percent chance is awful in biotech as most fail. The market is expecting an excellent readdout. Anything short is awful.

Iyot

@dewmoore i think most here misunderstand he potential in worth of the therapy. Not only do you have price targets of 20-35, there are about 25 million + shares sold short, combined with the validation of this tRNA therapy platform, no competition for at least 5 years, along with the drugs they have in the preclinical stage. 

I think it&#39;s possible to see very high inflections. 50, 60, maybe even more.

Fredo

TKM83

WOW! @PennyMagician great points you and @BioBingo  let&#39;s hope we are all right especially Wells Fargo&#39;s $58+ prediction shit is starting to add up in a good wayyyy!  I thought BioBingo was gonna rip me for saying they RIGGED the study for success LOL -- The primary reason for my  increased confidence in the BULL CASE $58+,  is the &quot;rigging AKA Strategic Design of the Phase 3 trial. LOL i did clean it up in the same sentence but that&#39;s how i thought of it

 i think most here misunderstand he potential in worth of the therapy. Not only do you have price targets of 20-35, there are about 25 million + shares sold short, combined with the validation of this tRNA therapy platform, no competition for at least 5 years, along with the drugs they have in the preclinical stage. 

I think it's possible to see very high inflections. 50, 60, maybe even more.

Welcome back!

@dewmoore thx. Witch day you predict will be data?

 thx. Witch day you predict will be data?

Gediminas Karalius

@PennyMagician i think you should REPOST my post and ADD your thinking to it too --- because i didn&#39;t have enough roooom for all of that which i left out ---- great job!

 i think you should REPOST my post and ADD your thinking to it too --- because i didn't have enough roooom for all of that which i left out ---- great job!

@Geukinas gonna work on that over the weekend hopefully will have monday -- gonna head to the bar and get a drink because WOWWWWW this thing is going to EXPLODE or IMPLODE no other way around it -- but based on them RIGGING it for PERFECTION **doesn&#39;t even have to get to perfection *** i see it hitting $20&#39;s for sure!!!! i&#39;ll take it but I&#39;ll really take the $40&#39;s and $50&#39;s

 gonna work on that over the weekend hopefully will have monday -- gonna head to the bar and get a drink because WOWWWWW this thing is going to EXPLODE or IMPLODE no other way around it -- but based on them RIGGING it for PERFECTION **doesn't even have to get to perfection *** i see it hitting $20's for sure!!!! i'll take it but I'll really take the $40's and $50's

@dewmoore so you think mondey they can realise? Should i invest today or monday?

 so you think mondey they can realise? Should i invest today or monday?

@Geukinas i don&#39;t tell you when i just make all of the scientific shit make sense to the little people like myself LOL GOOD LUCK i&#39;m already in

 i don't tell you when i just make all of the scientific shit make sense to the little people like myself LOL GOOD LUCK i'm already in

@dewmoore Please share a link to the report source. Can&#39;t find anything for August 7 from Wells Fargo

 Please share a link to the report source. Can't find anything for August 7 from Wells Fargo